HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.

Autor: Ali DE; Pharmacognosy and Natural Products Department, Faculty of Pharmacy, Pharos University, Alexandria, Egypt., Bassam SM; Pharmacognosy and Natural Products Department, Faculty of Pharmacy, Pharos University, Alexandria, Egypt., Elatrebi S; Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Habiba ES; Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Allam EA; Medical Physiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Omar EM; Medical Physiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Ghareeb DA; Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt., Abdulmalek SA; Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt., Abdel-Sattar E; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza, Egypt.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2023 Feb 28; Vol. 18 (2), pp. e0282246. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
DOI: 10.1371/journal.pone.0282246
Abstrakt: Yucca aloifolia L. fruit (Yucca or Spanish bayonet, family Asparagaceae) is recognized for its purplish red color reflecting its anthocyanin content, which has a powerful antioxidant activity. This study aimed to investigate yucca (YA) fruit extract's protective effect on Parkinson's disease (PD). In vitro study, the anti-inflammatory activity of yucca fruit extracts was explored by measuring tumor necrosis factor receptor 2 (TNF-R2) and nuclear factor kappa B (NF-KB) to choose the most effective extract. Afterward, a detailed in vivo investigation of the protective effect of the most active extract on rotenone-induced PD was performed on male albino Wister rats. First, the safety of the extract in two different doses (50 and 100 mg/kg in 0.9% saline orally) was confirmed by a toxicological study. The rats were divided into four groups: 1) normal control (NC); 2) rotenone group; and third and fourth groups received 50 and 100 mg/kg yucca extract, respectively. The neurobehavioral and locomotor activities of the rats were tested by rotarod, open field, and forced swim tests. Striatal dopamine, renal and liver functions, and oxidative stress markers were assessed. Western blot analysis of brain tissue samples was performed for p-AMPK, Wnt3a, and β-catenin. Histopathological examination of striatal tissue samples was performed by light and electron microscopy (EM). The metabolites of the active extract were characterized using high-resolution LC-MS/MS, and the results showed the prevalence of anthocyanins, saponins, phenolics, and choline. Biochemical and histopathological tests revealed a dose-dependent improvement with oral Yucca extract. The current study suggests a possible neuroprotective effect of the acidified 50% ethanol extract (YA-C) of the edible Yucca fruit, making it a promising therapeutic target for PD.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Ali et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje